Search the GHTC website

Global health R&D delivers for California

US government investment in global health R&D has delivered

$876.4 million
to California research institutions
11,800+ new jobs
for California
Global health R&D at work in California

Using a method developed at the University of California-San Francisco, Stanford University researchers have created a compound, still in early stages, that combats drug-resistant malaria parasites without harm to human cells. Despite global efforts, malaria infects nearly 200 million people each year, mostly in Africa and Asia, and kills more than 400,000—primarily children under five. Scientists are racing to find new treatments before current drugs stop working.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: PATH/Patrick McKern